Trials / Completed
CompletedNCT04526808
Effects of Low FODMAP Diet on Leaky Gut
Effects of Low FODMAP Diet on Leaky Gut and Mucosal Immune Cell Abundance in Diarrhea-predominant Irritable Bowel Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The pathophysiology of Irritable bowel syndrome (IBS) is multifactorial involving complex interplay of altered intestinal permeability, mucosal immune activation, visceral hypersensitivity and gut dysbiosis. Although the exact triggers for these pathological changes in IBS are not clear but diet might play an important role. In fact, several studies have reported improvement in gastrointestinal symptoms on a diet low in FODMAPs (LFD) in patients with IBS, specifically in diarrhea predominant IBS (IBS-D). However, the mechanism of action of LFD is not well understood.
Detailed description
we aim to evaluate the following in patients with IBS-D. The effect of LFD on colonic permeability. 2.The effect of LFD on abundance of colonic mucosal immune cells specifically T-cell and mast cell abundance 3.The effect of LFD on colonic mucosal microbiome
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FODMAP diet | low FODMAP diet |
Timeline
- Start date
- 2019-05-20
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2020-08-26
- Last updated
- 2025-05-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04526808. Inclusion in this directory is not an endorsement.